BioMérieux has launched Myla™, a revolutionary new middleware solution to improve connectivity, laboratory workflow and information management. As a world leader in in vitro diagnostics, bioMérieux understands the increasing pressure on clinical laboratory managers to deliver more efficient laboratory workflows and streamlined information management, and has developed Myla to help meet these needs.
Myla is an intelligent browser-based application that consolidates and manages microbiology data generated from a variety of sources, and converts these data into actionable information for treatment decisions. Designed to transform the way that laboratory managers and technicians work, Myla recaptures time spent on information retrieval and reporting activities, through a simple dashboard-based user interface that provides full control of laboratory workflow.
“Myla brings two key benefits to the microbiology laboratory: significantly improving operational efficiency and making the most relevant information readily available to clinicians so they can take action rapidly,” said Stéphane Bancel, Chief Executive Officer of bioMérieux. “Time to treatment makes a critical difference in patient outcomes and Myla is a fundamental part of bioMérieux’s Full Microbiology Lab Automation (FMLA™) strategy to deliver faster results.”